ARTICLE | Preclinical News
Neon improves predictions for CD4-stimulating tumor antigens
September 6, 2019 8:45 PM UTC
In the latest step toward breaking the barrier to identifying neoantigens displayed on MHCII, Neon has generated a systems biology model that outperforms publicly available predictors.
The development brings immuno-oncology closer to personalized therapies directing CD4+ T cells against tumor neoantigens...
BCIQ Company Profiles
BCIQ Target Profiles